These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 15865087)
1. Phase II trial of carboplatin, paclitaxel plus vinorelbine in non-small cell lung cancer patients. Schmittel A; Siehl JM; Schulze M; Schulze K; Thiel E; Keilholz U Anticancer Res; 2005; 25(2B):1333-6. PubMed ID: 15865087 [TBL] [Abstract][Full Text] [Related]
2. A phase I trial of paclitaxel plus carboplatin in untreated patients with advanced non-small cell lung cancer. Kelly K; Pan Z; Murphy J; Huffman DH; Bunn PA Clin Cancer Res; 1997 Jul; 3(7):1117-23. PubMed ID: 9815791 [TBL] [Abstract][Full Text] [Related]
3. Phase II study of oral vinorelbine in combination with carboplatin followed by consolidation therapy with oral vinorelbine as single-agent in unresectable localized or metastatic non-small cell lung carcinoma. Reck M; Macha HN; Del Barco S; Cornes P; Vaissière N; Morand M; Riggi M; Abratt R Lung Cancer; 2009 Jun; 64(3):319-25. PubMed ID: 19095327 [TBL] [Abstract][Full Text] [Related]
4. Paclitaxel, carboplatin, and vinorelbine in the treatment of advanced non-small cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network. Hainsworth JD; Burris HA; Morrissey LH; Thomas M; Erland JB; Butts JA; Joseph G; Kalman L; Greco FA Cancer J; 2000; 6(3):151-6. PubMed ID: 10882330 [TBL] [Abstract][Full Text] [Related]
5. The combination of carboplatin and weekly paclitaxel: a safe and active regimen in advanced non small-cell lung cancer patients. A phase I-II study. Fabi A; Barduagni M; Ferraresi V; Cortesi E; Gamucci T; De Marinis F; Saltarelli R; Gabriele A; Pellicciotta M; Ceribelli A; De Marco S; Facciolo F; Cognetti F J Exp Clin Cancer Res; 2004 Mar; 23(1):25-32. PubMed ID: 15149147 [TBL] [Abstract][Full Text] [Related]
6. A phase II study of carboplatin and paclitaxel as first line chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC). Giorgio CG; Pappalardo A; Russo A; Giuffrida D; Santini D; Petralia G; Castorina S; Nunzio R; Failla G; Bordonaro R Lung Cancer; 2006 Mar; 51(3):357-62. PubMed ID: 16406602 [TBL] [Abstract][Full Text] [Related]
7. Induction chemotherapy with paclitaxel plus carboplatin followed by paclitaxel with concurrent radiotherapy in stage IIIB non-small-cell lung cancer (NSCLC) patients: a phase II trial. Pallarés C; Capdevila J; Paredes A; Farré N; Ciria JP; Membrive I; Basterrechea L; Gomez-Segura G; Barnadas A Lung Cancer; 2007 Nov; 58(2):238-45. PubMed ID: 17658655 [TBL] [Abstract][Full Text] [Related]
8. Phase II trial of carboplatin and paclitaxel in non-small cell lung cancer patients previously treated with chemotherapy. Yoh K; Kubota K; Kakinuma R; Ohmatsu H; Goto K; Niho S; Saijo N; Nishiwaki Y Lung Cancer; 2007 Oct; 58(1):73-9. PubMed ID: 17548127 [TBL] [Abstract][Full Text] [Related]
9. Concurrent chemoradiotherapy with vinorelbine and a platinum compound followed by consolidation chemotherapy for unresectable stage III non-small cell lung cancer: preliminary results of a phase II study. Rusu P; Ciuleanu TE; Cernea D; Pelau D; Gaal V; Cebotaru C; Guttman T; Todor N; Ghilezan N J BUON; 2007; 12(1):33-9. PubMed ID: 17436399 [TBL] [Abstract][Full Text] [Related]
10. [Combination chemotherapy with carboplatin and weekly Paclitaxel in patients with advanced non-small cell lung cancer]. Hashizume T; Ogura T; Kozawa S; Yamaguchi N; Hayashi M; Nakamura M; Miyazawa N; Watanuki Y; Takahashi H Gan To Kagaku Ryoho; 2006 Apr; 33(4):471-5. PubMed ID: 16612156 [TBL] [Abstract][Full Text] [Related]
11. A multicenter phase II study of carboplatin and paclitaxel with a biweekly schedule in patients with advanced non-small-cell lung cancer: Kyushu thoracic oncology group trial. Ichiki M; Kawasaki M; Takayama K; Ninomiya K; Kuba M; Iwami F; Miyazaki N; Oishi K; Takeo S; Aizawa H; Nakanishi Y Cancer Chemother Pharmacol; 2006 Sep; 58(3):368-73. PubMed ID: 16395589 [TBL] [Abstract][Full Text] [Related]
12. Randomized, phase III study of weekly paclitaxel in combination with carboplatin versus standard every-3-weeks administration of carboplatin and paclitaxel for patients with previously untreated advanced non-small-cell lung cancer. Belani CP; Ramalingam S; Perry MC; LaRocca RV; Rinaldi D; Gable PS; Tester WJ J Clin Oncol; 2008 Jan; 26(3):468-73. PubMed ID: 18202422 [TBL] [Abstract][Full Text] [Related]
13. A phase II study of weekly paclitaxel combined with carboplatin for elderly patients with advanced non-small cell lung cancer. Inoue A; Usui K; Ishimoto O; Matsubara N; Tanaka M; Kanbe M; Gomi K; Koinumaru S; Saijo Y; Nukiwa T Lung Cancer; 2006 Apr; 52(1):83-7. PubMed ID: 16483687 [TBL] [Abstract][Full Text] [Related]
14. Phase II study of carboplatin and weekly paclitaxel in advanced non-small cell lung cancer. Nakadate M; Yamazaki K; Konishi J; Kinoshita I; Sukoh N; Harada M; Akie K; Ogura S; Ishida T; Munakata M; Dosaka-Akita H; Isobe H; Nishimura M Anticancer Res; 2006; 26(5B):3767-72. PubMed ID: 17094399 [TBL] [Abstract][Full Text] [Related]
15. A phase I/randomized phase II, non-comparative, multicenter, open label trial of CP-547,632 in combination with paclitaxel and carboplatin or paclitaxel and carboplatin alone as first-line treatment for advanced non-small cell lung cancer (NSCLC). Cohen RB; Langer CJ; Simon GR; Eisenberg PD; Hainsworth JD; Madajewicz S; Cosgriff TM; Pierce K; Xu H; Liau K; Healey D Cancer Chemother Pharmacol; 2007 Jun; 60(1):81-9. PubMed ID: 17031646 [TBL] [Abstract][Full Text] [Related]
17. Phase II study of 24-hour infusion of paclitaxel (Intaxel) with carboplatin in advanced non-small cell lung cancer. Charoentum C; Thongprasert S; Chewasakulyong B Gan To Kagaku Ryoho; 2007 Oct; 34(10):1603-7. PubMed ID: 17940374 [TBL] [Abstract][Full Text] [Related]
18. Phase II study of a biweekly regimen of vinorelbine and cisplatin in advanced non-small cell lung cancer. Chen CH; Lin CM; Kao KC; Chang JW; Tsao TC Chang Gung Med J; 2007; 30(3):249-55. PubMed ID: 17760276 [TBL] [Abstract][Full Text] [Related]
19. Phase III trial of paclitaxel plus carboplatin with or without tirapazamine in advanced non-small-cell lung cancer: Southwest Oncology Group Trial S0003. Williamson SK; Crowley JJ; Lara PN; McCoy J; Lau DH; Tucker RW; Mills GM; Gandara DR; J Clin Oncol; 2005 Dec; 23(36):9097-104. PubMed ID: 16361616 [TBL] [Abstract][Full Text] [Related]
20. Phase I/II study of atrasentan, an endothelin A receptor antagonist, in combination with paclitaxel and carboplatin as first-line therapy in advanced non-small cell lung cancer. Chiappori AA; Haura E; Rodriguez FA; Boulware D; Kapoor R; Neuger AM; Lush R; Padilla B; Burton M; Williams C; Simon G; Antonia S; Sullivan DM; Bepler G Clin Cancer Res; 2008 Mar; 14(5):1464-9. PubMed ID: 18316570 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]